PGP and diabetes mellitus: Several studies have demonstrated that diabetes impairs expression and function of intestinal P-gp, leading to the enhancement of intestinal absorption and increasing plasma exposure following oral administration of P-gp substrates such as arctigenin [81], protoberberine alkaloids [82], digoxin [83], grepafloxacin [84], paclitaxel [17] and morphine [85].